Management of Venous and Arterial Thrombosis

This reprint focuses on research on arterial and venous thromboembolic complications. The authors provide up-to-date information about the pathogenesis, risk stratification, diagnostics and treatment of various forms of thromboembolism including venous thrombosis, pulmonary embolism, cerebral sinus...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Format: Buch
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
description This reprint focuses on research on arterial and venous thromboembolic complications. The authors provide up-to-date information about the pathogenesis, risk stratification, diagnostics and treatment of various forms of thromboembolism including venous thrombosis, pulmonary embolism, cerebral sinus thrombosis, splanchnic thrombosis, ischemic stroke, acute coronary syndrome and pregnancy loss. Additionally, they included the advances of such management in specific populations, such as the patients with endocrine disorders, cancer or COVID-19.
doi_str_mv 10.3390/books978-3-7258-1180-9
format Book
fullrecord <record><control><sourceid>oapen</sourceid><recordid>TN_cdi_oapen_doabooks_139328</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>139328</sourcerecordid><originalsourceid>FETCH-LOGICAL-g1039-99a6d8ddab80f392a64713ca19cd45886ea65111781bf9b40914dfaf924439403</originalsourceid><addsrcrecordid>eNotj8tKQzEURQMiKPX-gcj9AKM59-R1hqX4goqT6rScNEm92CZyU__f-hgtWIPF3kJcgbpBJHUbav1o5LxE6QbjJYBXkk5Ed3T4YwAc4ZnoWhuDMsZr56w5F9fPXHib9qkc-pr7t1TqV-u5xH4-HdI08q5fvU91H2ob24U4zbxrqfvnTLze360Wj3L58vC0mC_lFhSSJGIbfYwcvMpIA1vtADcMtInaeG8TWwPHQR5CpqAVgY6ZMw1aI2mFM3H51638mco6Vv69twYkHDx-AwY3QpI</addsrcrecordid><sourcetype>Publisher</sourcetype><iscdi>true</iscdi><recordtype>book</recordtype></control><display><type>book</type><title>Management of Venous and Arterial Thrombosis</title><source>DOAB: Directory of Open Access Books</source><contributor>Kubisz, Peter ; Stan?iaková, Lucia ; Othman, Maha</contributor><creatorcontrib>Kubisz, Peter ; Stan?iaková, Lucia ; Othman, Maha</creatorcontrib><description>This reprint focuses on research on arterial and venous thromboembolic complications. The authors provide up-to-date information about the pathogenesis, risk stratification, diagnostics and treatment of various forms of thromboembolism including venous thrombosis, pulmonary embolism, cerebral sinus thrombosis, splanchnic thrombosis, ischemic stroke, acute coronary syndrome and pregnancy loss. Additionally, they included the advances of such management in specific populations, such as the patients with endocrine disorders, cancer or COVID-19.</description><identifier>ISBN: 9783725811793</identifier><identifier>ISBN: 9783725811809</identifier><identifier>ISBN: 3725811792</identifier><identifier>ISBN: 3725811806</identifier><identifier>DOI: 10.3390/books978-3-7258-1180-9</identifier><language>eng</language><publisher>MDPI - Multidisciplinary Digital Publishing Institute</publisher><subject>acute coronary syndrome ; acute mesenteric ischemia ; adverse thrombotic and hemorrhagic events ; anticoagulants ; anticoagulation ; antiplatelet therapy ; antithrombotic treatment ; aortopathy ; arterial thrombosis ; aspirin ; atrial fibrillation ; bicuspid aortic valve ; biomarker ; blood coagulation cascade ; cancer ; cangrelor ; catheter-based therapies ; cerebral venous sinus thrombosis ; children ; classification ; Clinical and internal medicine ; CNS ; coagulation ; coronary artery thrombosis ; COVID-19 ; data mining ; diagnosis ; direct oral anticoagulants ; DNA analysis ; DOAC laboratory monitoring ; embolism ; endothelial dysfunction ; endovascular therapy ; fibrinolysis ; haemorrhagic ; haemostasis ; heme ; hemolysis ; high on-treatment platelet reactivity ; hyperaggregability ; hyperthyroidism ; inflammation ; intracerebral hemorrhage ; ischaemic ; knowledge graph ; lactate ; Medicine and Nursing ; morbidity ; mortality ; myocardial infarction ; n/a ; neutrophil extracellular traps (NETs) ; panel ; PCSK9 monoclonal antibodies ; PERT ; platelet activation ; polymorphisms ; prasugrel ; prediction values ; prognosis ; prothrombotic ; pulmonary embolism ; pulmonary embolism response team ; quality improvement ; recurrence ; risk assessment ; risk of thrombosis ; risk stratification ; SARS-CoV-2 infection ; score ; sensitivity ; specificity ; stent thrombosis ; sticky platelet syndrome ; stroke ; tailored medicine ; thrombectomy ; thrombolysis ; thrombophilia ; thrombosis ; thrombus ; ticagrelor ; TNF-related apoptosis-inducing ligand ; treatment ; triage ; venous thromboembolism ; VITT ; VTE prophylaxis ; young adults</subject><creationdate>2024</creationdate><tpages>282</tpages><format>282</format><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>306,776,780,782,27902,55285</link.rule.ids></links><search><contributor>Kubisz, Peter</contributor><contributor>Stan?iaková, Lucia</contributor><contributor>Othman, Maha</contributor><title>Management of Venous and Arterial Thrombosis</title><description>This reprint focuses on research on arterial and venous thromboembolic complications. The authors provide up-to-date information about the pathogenesis, risk stratification, diagnostics and treatment of various forms of thromboembolism including venous thrombosis, pulmonary embolism, cerebral sinus thrombosis, splanchnic thrombosis, ischemic stroke, acute coronary syndrome and pregnancy loss. Additionally, they included the advances of such management in specific populations, such as the patients with endocrine disorders, cancer or COVID-19.</description><subject>acute coronary syndrome</subject><subject>acute mesenteric ischemia</subject><subject>adverse thrombotic and hemorrhagic events</subject><subject>anticoagulants</subject><subject>anticoagulation</subject><subject>antiplatelet therapy</subject><subject>antithrombotic treatment</subject><subject>aortopathy</subject><subject>arterial thrombosis</subject><subject>aspirin</subject><subject>atrial fibrillation</subject><subject>bicuspid aortic valve</subject><subject>biomarker</subject><subject>blood coagulation cascade</subject><subject>cancer</subject><subject>cangrelor</subject><subject>catheter-based therapies</subject><subject>cerebral venous sinus thrombosis</subject><subject>children</subject><subject>classification</subject><subject>Clinical and internal medicine</subject><subject>CNS</subject><subject>coagulation</subject><subject>coronary artery thrombosis</subject><subject>COVID-19</subject><subject>data mining</subject><subject>diagnosis</subject><subject>direct oral anticoagulants</subject><subject>DNA analysis</subject><subject>DOAC laboratory monitoring</subject><subject>embolism</subject><subject>endothelial dysfunction</subject><subject>endovascular therapy</subject><subject>fibrinolysis</subject><subject>haemorrhagic</subject><subject>haemostasis</subject><subject>heme</subject><subject>hemolysis</subject><subject>high on-treatment platelet reactivity</subject><subject>hyperaggregability</subject><subject>hyperthyroidism</subject><subject>inflammation</subject><subject>intracerebral hemorrhage</subject><subject>ischaemic</subject><subject>knowledge graph</subject><subject>lactate</subject><subject>Medicine and Nursing</subject><subject>morbidity</subject><subject>mortality</subject><subject>myocardial infarction</subject><subject>n/a</subject><subject>neutrophil extracellular traps (NETs)</subject><subject>panel</subject><subject>PCSK9 monoclonal antibodies</subject><subject>PERT</subject><subject>platelet activation</subject><subject>polymorphisms</subject><subject>prasugrel</subject><subject>prediction values</subject><subject>prognosis</subject><subject>prothrombotic</subject><subject>pulmonary embolism</subject><subject>pulmonary embolism response team</subject><subject>quality improvement</subject><subject>recurrence</subject><subject>risk assessment</subject><subject>risk of thrombosis</subject><subject>risk stratification</subject><subject>SARS-CoV-2 infection</subject><subject>score</subject><subject>sensitivity</subject><subject>specificity</subject><subject>stent thrombosis</subject><subject>sticky platelet syndrome</subject><subject>stroke</subject><subject>tailored medicine</subject><subject>thrombectomy</subject><subject>thrombolysis</subject><subject>thrombophilia</subject><subject>thrombosis</subject><subject>thrombus</subject><subject>ticagrelor</subject><subject>TNF-related apoptosis-inducing ligand</subject><subject>treatment</subject><subject>triage</subject><subject>venous thromboembolism</subject><subject>VITT</subject><subject>VTE prophylaxis</subject><subject>young adults</subject><isbn>9783725811793</isbn><isbn>9783725811809</isbn><isbn>3725811792</isbn><isbn>3725811806</isbn><fulltext>true</fulltext><rsrctype>book</rsrctype><creationdate>2024</creationdate><recordtype>book</recordtype><sourceid>V1H</sourceid><recordid>eNotj8tKQzEURQMiKPX-gcj9AKM59-R1hqX4goqT6rScNEm92CZyU__f-hgtWIPF3kJcgbpBJHUbav1o5LxE6QbjJYBXkk5Ed3T4YwAc4ZnoWhuDMsZr56w5F9fPXHib9qkc-pr7t1TqV-u5xH4-HdI08q5fvU91H2ob24U4zbxrqfvnTLze360Wj3L58vC0mC_lFhSSJGIbfYwcvMpIA1vtADcMtInaeG8TWwPHQR5CpqAVgY6ZMw1aI2mFM3H51638mco6Vv69twYkHDx-AwY3QpI</recordid><startdate>2024</startdate><enddate>2024</enddate><general>MDPI - Multidisciplinary Digital Publishing Institute</general><scope>V1H</scope></search><sort><creationdate>2024</creationdate><title>Management of Venous and Arterial Thrombosis</title></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-g1039-99a6d8ddab80f392a64713ca19cd45886ea65111781bf9b40914dfaf924439403</frbrgroupid><rsrctype>books</rsrctype><prefilter>books</prefilter><language>eng</language><creationdate>2024</creationdate><topic>acute coronary syndrome</topic><topic>acute mesenteric ischemia</topic><topic>adverse thrombotic and hemorrhagic events</topic><topic>anticoagulants</topic><topic>anticoagulation</topic><topic>antiplatelet therapy</topic><topic>antithrombotic treatment</topic><topic>aortopathy</topic><topic>arterial thrombosis</topic><topic>aspirin</topic><topic>atrial fibrillation</topic><topic>bicuspid aortic valve</topic><topic>biomarker</topic><topic>blood coagulation cascade</topic><topic>cancer</topic><topic>cangrelor</topic><topic>catheter-based therapies</topic><topic>cerebral venous sinus thrombosis</topic><topic>children</topic><topic>classification</topic><topic>Clinical and internal medicine</topic><topic>CNS</topic><topic>coagulation</topic><topic>coronary artery thrombosis</topic><topic>COVID-19</topic><topic>data mining</topic><topic>diagnosis</topic><topic>direct oral anticoagulants</topic><topic>DNA analysis</topic><topic>DOAC laboratory monitoring</topic><topic>embolism</topic><topic>endothelial dysfunction</topic><topic>endovascular therapy</topic><topic>fibrinolysis</topic><topic>haemorrhagic</topic><topic>haemostasis</topic><topic>heme</topic><topic>hemolysis</topic><topic>high on-treatment platelet reactivity</topic><topic>hyperaggregability</topic><topic>hyperthyroidism</topic><topic>inflammation</topic><topic>intracerebral hemorrhage</topic><topic>ischaemic</topic><topic>knowledge graph</topic><topic>lactate</topic><topic>Medicine and Nursing</topic><topic>morbidity</topic><topic>mortality</topic><topic>myocardial infarction</topic><topic>n/a</topic><topic>neutrophil extracellular traps (NETs)</topic><topic>panel</topic><topic>PCSK9 monoclonal antibodies</topic><topic>PERT</topic><topic>platelet activation</topic><topic>polymorphisms</topic><topic>prasugrel</topic><topic>prediction values</topic><topic>prognosis</topic><topic>prothrombotic</topic><topic>pulmonary embolism</topic><topic>pulmonary embolism response team</topic><topic>quality improvement</topic><topic>recurrence</topic><topic>risk assessment</topic><topic>risk of thrombosis</topic><topic>risk stratification</topic><topic>SARS-CoV-2 infection</topic><topic>score</topic><topic>sensitivity</topic><topic>specificity</topic><topic>stent thrombosis</topic><topic>sticky platelet syndrome</topic><topic>stroke</topic><topic>tailored medicine</topic><topic>thrombectomy</topic><topic>thrombolysis</topic><topic>thrombophilia</topic><topic>thrombosis</topic><topic>thrombus</topic><topic>ticagrelor</topic><topic>TNF-related apoptosis-inducing ligand</topic><topic>treatment</topic><topic>triage</topic><topic>venous thromboembolism</topic><topic>VITT</topic><topic>VTE prophylaxis</topic><topic>young adults</topic><toplevel>online_resources</toplevel><collection>DOAB: Directory of Open Access Books</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kubisz, Peter</au><au>Stan?iaková, Lucia</au><au>Othman, Maha</au><format>book</format><genre>book</genre><ristype>BOOK</ristype><btitle>Management of Venous and Arterial Thrombosis</btitle><date>2024</date><risdate>2024</risdate><isbn>9783725811793</isbn><isbn>9783725811809</isbn><isbn>3725811792</isbn><isbn>3725811806</isbn><abstract>This reprint focuses on research on arterial and venous thromboembolic complications. The authors provide up-to-date information about the pathogenesis, risk stratification, diagnostics and treatment of various forms of thromboembolism including venous thrombosis, pulmonary embolism, cerebral sinus thrombosis, splanchnic thrombosis, ischemic stroke, acute coronary syndrome and pregnancy loss. Additionally, they included the advances of such management in specific populations, such as the patients with endocrine disorders, cancer or COVID-19.</abstract><pub>MDPI - Multidisciplinary Digital Publishing Institute</pub><doi>10.3390/books978-3-7258-1180-9</doi><tpages>282</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISBN: 9783725811793
ispartof
issn
language eng
recordid cdi_oapen_doabooks_139328
source DOAB: Directory of Open Access Books
subjects acute coronary syndrome
acute mesenteric ischemia
adverse thrombotic and hemorrhagic events
anticoagulants
anticoagulation
antiplatelet therapy
antithrombotic treatment
aortopathy
arterial thrombosis
aspirin
atrial fibrillation
bicuspid aortic valve
biomarker
blood coagulation cascade
cancer
cangrelor
catheter-based therapies
cerebral venous sinus thrombosis
children
classification
Clinical and internal medicine
CNS
coagulation
coronary artery thrombosis
COVID-19
data mining
diagnosis
direct oral anticoagulants
DNA analysis
DOAC laboratory monitoring
embolism
endothelial dysfunction
endovascular therapy
fibrinolysis
haemorrhagic
haemostasis
heme
hemolysis
high on-treatment platelet reactivity
hyperaggregability
hyperthyroidism
inflammation
intracerebral hemorrhage
ischaemic
knowledge graph
lactate
Medicine and Nursing
morbidity
mortality
myocardial infarction
n/a
neutrophil extracellular traps (NETs)
panel
PCSK9 monoclonal antibodies
PERT
platelet activation
polymorphisms
prasugrel
prediction values
prognosis
prothrombotic
pulmonary embolism
pulmonary embolism response team
quality improvement
recurrence
risk assessment
risk of thrombosis
risk stratification
SARS-CoV-2 infection
score
sensitivity
specificity
stent thrombosis
sticky platelet syndrome
stroke
tailored medicine
thrombectomy
thrombolysis
thrombophilia
thrombosis
thrombus
ticagrelor
TNF-related apoptosis-inducing ligand
treatment
triage
venous thromboembolism
VITT
VTE prophylaxis
young adults
title Management of Venous and Arterial Thrombosis
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-11T18%3A09%3A12IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-oapen&rft_val_fmt=info:ofi/fmt:kev:mtx:book&rft.genre=book&rft.btitle=Management%20of%20Venous%20and%20Arterial%20Thrombosis&rft.au=Kubisz,%20Peter&rft.date=2024&rft.isbn=9783725811793&rft.isbn_list=9783725811809&rft.isbn_list=3725811792&rft.isbn_list=3725811806&rft_id=info:doi/10.3390/books978-3-7258-1180-9&rft_dat=%3Coapen%3E139328%3C/oapen%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true